How to manage diabetes mellitus in older persons in the 21st century: Applying these principles to long term diabetes care

Journal of the American Medical Directors Association

Volumn 14, Issue 11, 2013, Pages 777-780

  Sinclair, Alan ^a   Morley, John E ^b  

^a UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

COMORBIDITY; DEMENTIA; DIABETES MELLITUS; EDITORIAL; EXERCISE; FUNCTIONAL STATUS; GERIATRIC CARE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LIFE EXPECTANCY; LONG TERM CARE; NURSING HOME PATIENT; POLYPHARMACY; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; AGED; COGNITION DISORDERS; DIABETES MELLITUS; DISABLED PERSONS; DISEASE MANAGEMENT; FRAIL ELDERLY; HUMANS; LONG-TERM CARE; MASS SCREENING; MIDDLE AGED; PALLIATIVE CARE; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES;

EID: 84886785594     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.09.001     Document Type: Editorial

References (76)

1. Sinclair A., Morley J.E., Rodriguez-Mañas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. JAm Med Dir Assoc 2012, 13:497-502.
2. Kirkman S.M., Briscoe V.J., Clark N., et al. Consensus Development Conference on Diabetes and Older Adults. Diabetes in older adults. A consensus report. JAm Geriatr Soc 2012, 60:2342-2356.
3. Sinclair A.J., Paolisso G., Castro M., et al. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011, 37:S27-S38.
4. Herzig Mallery L., Ransom T., Steeves B., et al. Evidence-informed guidelines for treating frail older adults with type 2 diabetes from the Diabetes Care Program of Nova Scotia (DCPNS) and Palliative and Therapeutic Harmonization (PATH) Program. JAm Med Dir Assoc 2013, 14:801-808.
5. Newton C.A., Adeel S., Sadeghi-Yarandi S., et al. Prevalence, quality of care, and complications in long-term care residents with diabetes: A multicenter observational study. JAm Med Dir Assoc 2013, 14:842-846.
6. Hager K.K., Loprinzi P., Stone D. Implementing diabetes care guidelines in long term care. JAm Med Dir Assoc 2013, 14:851.e7-851.e15.
7. Boyle P.J., O'Neil K.W., Berry C.A., et al. Improving diabetes care and patient outcomes in skilled-care communities: Successes and lessons from a quality improvement initiative. JAm Med Dir Assoc 2013, 14:340-344.
8. Morley J.E. Diabetes mellitus: "The times they are a-changin". JAm Med Dir Assoc 2012, 13:574-575.
9. Migdal A., Yarandi S.S., Smiley D., Umpierrez G.E. Update on diabetes in the elderly and in nursing home residents. JAm Med Dir Assoc 2011, 12:627-632.e2.
10. Vischer U.M. Glycemic targets for elderly diabetic patients need reappraisal. JAm Med Dir Assoc 2011, 12:9-11.
11. Chen L.K., Peng L.N., Lin M.H., et al. Diabetes mellitus, glycemic control, and pneumonia in long-term care facilities: A 2-year, prospective cohort study. JAm Med Dir Assoc 2011, 12:33-37.
12. Feldman S.M., Rosen R., DeStasio J. Status of diabetes management in the nursing home setting in 2008: A retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management. JAm Med Dir Assoc 2009, 10:354-360.
13. Joseph J., Koka M., Aronow W.S. Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home. JAm Med Dir Assoc 2008, 9:51-54.
14. Meyers R.M., Broton J.C., Woo-Rippe K.W., et al. Variability in glycosylated hemoglobin values in diabetic patients living in long-term care facilities. JAm Med Dir Assoc 2007, 8:511-514.
15. Yau C.K., Eng C., Cenzer I.S., et al. Glysosylated hemoglobin and functional decline in community-dwelling nursing home-eligible elderly adults with diabetes mellitus. JAm Geriatr Soc 2012, 60:1215-1221.
16. Morley J.E., Vellas B., van Kan G.A., et al. Frailty consensus: A call to action. JAm Med Dir Assoc 2013, 14:392-397.
17. Sinclair A., Morley J.E. Frailty and diabetes. Lancet 2013, doi:pii:S0140-6736(13-61676-1 [Epub ahead of print].
18. Morley J.E., Malmstrom T.K., Miller D.K. Asimple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. JNutr Health Aging 2012, 16:601-608.
19. Rouge Bugat M.E., Cestac P., Oustric S., et al. Detecting frailty in primary care: A major challenge for primary care physicians. JAm Med Dir Assoc 2012, 13:669-672.
20. Abellan van Kan G., Rolland Y.M., Morley J.E., Vellas B. Frailty: Toward a clinical definition. JAm Med Dir Assoc 2008, 9:71-72.
21. Ravindrarajah R., Lee D.M., Pye S.R., et al. The ability of three different models of frailty to predict all-cause mortality: Results from the European Male Aging Study (EMAS). Arch Gerontol Geriatr 2013, 57:360-368.
22. Bouillon K., Kivimaki M., Hamer M., et al. Diabetes risk factors, diabetes risk algorithms and the prediction of future frailty: The Whitehall II Prospective Cohort Study. JAm Med Dir Assoc 2013, 14:851.e1-851.e6.
23. Rockwood K., Abeysundera M.J., Mitnitski A. How should we grade frailty in nursing home patients?. JAm Med Dir Assoc 2007, 8:595-603.
24. Howlett S.E., Rockwood K. New horizons in frailty: Ageing and the deficit-scaling problem. Age Ageing 2013, 42:416-423.
25. Cruz-Oliver D.M., Malmstrom T.K., Allen C.M., et al. The Veterans Affairs Saint Louis University mental status exam (SLUMS exam) and the mini-mental status exam as predictors of mortality and institutionalization. JNutr Health Aging 2012, 16:636-641.
26. Tariq S.H., Tumosa N., Chibnall J.T., et al. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder-a pilot study. Am J Geriatr Psychiatry 2006, 14:900-910.
27. Morley J.E. Dementia-related agitation. JAm Med Dir Assoc 2011, 12:611-612.e2.
28. Morley J.E. Alzheimer's disease: Future treatments. JAm Med Dir Assoc 2011, 12:1-7.
29. Morley J.E. Editorial: Can we improve care for patients with dementia?. JNutr Health Aging 2011, 15:523-525.
30. Sinclair A.J., Gadsby R., Hillson R., et al. Brief report: Use of the Mini-Cog as a screening tool for cognitive impairment in diabetes in primary care. Diabetes Res Clin Pract 2013, 100:e23-e25.
31. Morley J.E. End-of-life care in the nursing home. JAm Med Dir Assoc 2011, 12:77-83.
32. Benetos A., Novella J.-L., Guerci B., et al. Pragmatic diabetes management innursing homes: Individual Care Plan. JAm Med Dir Assoc 2013, 14:791-800.
33. Anonymous United Kingdom prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995, 310:83-88.
34. Andujar-Plata P., Pi-Sunyer X., Laferrere B. Metformin effects revisited. Diabetes Res Clin Pract 2012, 95:1-9.
35. Lee A., Morley J.E. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res 1998, 6:47-53.
36. Erhardt W., Bergenheim K., Duprat-Lomon I., McEwan P. Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: A Cardiff diabetes model analysis. Clin Drug Investig 2012, 32:189-202.
37. Morley J.E., Sinclair A.J. Individualising treatment for older people with diabetes. Lancet 2013, 382:378-380.
38. Abdelhafiz A.H., Sinclair A.J. Management of type 2 diabetes in older people. Diabetes Ther 2013, 4:13-26.
39. Lecka-Czernik B. Bone loss in diabetes: Use of antidiabetic thiazolidinediones and secondary osteoporosis. Curr Osteoporos Rep 2010, 8:178-184.
40. Lee A., Patrick P., Wishart J., et al. The effects of miglitol on glucagon-like peptide-1 secrtion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab 2002, 4:329-335.
41. DeLeon M.J., Chandurkar V., Albert S.G., Mooradian A.D. Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects. Diabetes Res Clin Pract 2002, 56:101-106.
42. Van Brunt K., Curtis B., Brooks K., et al. Insulin use in long-term care settings for patients with type 2 diabetes mellitus: A systematic review of the literature. JAm Med Dir Assoc 2013, 14:809-816.
43. Pandya N., Nathanson E. Managing diabetes in long-term care facilities: Benefits of switching from human insulin to insulin analogs. JAm Med Dir Assoc 2010, 11:171-178.
44. Haas L.B. Optimizing insulin use in type 2 diabetes: Role of basal and prandial insulin in long-term care facilities. JAm Med Dir Assoc 2007, 8:502-510.
45. Kumari J., Dharmarajan T.S. Insulin glargine induced persistent intractable hypoglycemia, with variable presentations in older diabetic patients: An experience of 4 cases. JAm Med Dir Assoc 2009, 10:672-673.
46. Pandya N., Thompson S., Sambamoorthi U. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus. JAm Med Dir Assoc 2008, 9:663-669.
47. Tariq S.H., Karcic E., Thomas D.R., et al. The use of a no-concentrated-sweets diet in the management of type 2 diabetes in nursing homes. JAm Diet Assoc 2001, 101:1463-1466.
48. Mooradian A.D., Osterweil D., Petrasek D., Morley J.E. Diabetes mellitus in elderly nursing home patients. A survey of clinical characteristics and management. JAm Geriatr Soc 1988, 36:391-396.
49. Meyers R.M., Reger L. Diabetes management in long-term care facilities: A practical guide. JAm Med Dir Assoc 2009, 10:589.
50. Mazza A.D., Morley J.E. Update on diabetes in the elderly and the application of current therapeutics. JAm Med Dir Assoc 2007, 8:489-492.
51. Colberg S.R., Zarrabi L.V., Bennington L., et al. Postprandial walking is better for lowering the glycemic effect of dinner than pre-dinner exercise in type 2 diabetic individuals. JAm Med Dir Assoc 2009, 10:394-397.
52. Landi F., Onder G., Bernabei R. Sarcopenia and diabetes: Two sides of the same coin. JAm Med Dir Assoc 2013, 14:540-541.
53. Leenders M., Verdijk L.B., van der Hoeven L., et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. JAm Med Dir Assoc 2013, 14:585-592.
54. Singh N.A., Quine S., Clemson L.M., et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. JAm Med Dir Assoc 2012, 13:24-30.
55. Fielding R.A., Vellas B., Evans W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. JAm Med Dir Assoc 2011, 12:249-256.
56. Morley J.E. Frailty: Diagnosis and management. JNutr Health Aging 2011, 15:667-670.
57. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
58. Theou O., Brothers T.D., Rockwood M.R., et al. Exploring the relationship between national economic indicators and relative fitness and frailty in middle-aged and older Europeans. Age Ageing 2013, 42:614-619.
59. Onder G., Liperoti R., Foebel A., et al. Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: Results from the SHELTER study. JAm Med Dir Assoc 2013, 14:450.e7-450.e12.
60. Flaherty J.H., Perry H.M., Lynchard G.S., Morley J.E. Polypharmacy and hospitalization among older home care patients. JGerontol A Biol Sci Med Sci 2000, 55:M554-M559.
61. Kojima G., Bell C., Tamura B., et al. Reducing cost by reducing polypharmacy: The polypharmacy outcomes project. JAm Med Dir Assoc 2012, 13:818.e11-818.e15.
62. Bronskill S.E., Gill S.S., Paterson J.M., et al. Exploring variation in rates of polypharmacy across long term care homes. JAm Med Dir Assoc 2012, 13:309.e15-309.e21.
63. Tamura B.K., Bell C.L., Lubimir K., et al. Physician intervention for medication reduction in a nursing home: The polypharmacy outcomes project. JAm Med Dir Assoc 2011, 12:326-330.
64. Morley J.E. Systolic hypertension should not be treated in persons aged 80 and older until blood pressure is greater than 160 mm Hg. JAm Geriatr Soc 2013, 61:1197-1198.
65. Morley J.E. Hypertension: Is it overtreated in the elderly?. JAm Med Dir Assoc 2010, 11:147-152.
66. Morley J.E. Caring for the vulnerable elderly: Are available quality indicators appropriate?. JAm Med Dir Assoc 2008, 9:1-3.
67. Morley J.E. The cholesterol conundrum. JAm Geriatr Soc 2011, 59:1955-1956.
68. Padala K.P., Padala P.R., McNeilly D.P., et al. The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: A prospective withdrawal and rechallenge pilot study. Am J Geriatr Pharmacother 2012, 10:296-302.
69. Gadsby R., Galloway M., Barker P., Sinclair A. Prescribed medicines for elderly frail people with diabetes resident in nursing homes-issues of polypharmacy and medication costs. Diabet Med 2012, 29:136-139.
70. Niewoehner C.B., Allen J.I., Boosalis M., et al. Role of zinc supplementation in type II diabetes mellitus. Am J Med 1986, 81:63-68.
71. Mooradian A.D., Morley J.E. Micronutrient status in diabetes mellitus. Am J Clin Nutr 1987, 45:877-895.
72. Morley J.E., Mooradian A.D., Rosenthal M.J., Kaiser F.E. Diabetes mellitus in elderly patients. Is it different?. Am J Med 1987, 83:533-544.
73. Flood J.F., Mooradian A.D., Morley J.E. Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes 1990, 39:1391-1398.
74. Morley G.K., Mooradian A.D., Levine A.S., Morley J.E. Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am J Med 1984, 77:79-82.
75. Morley J.E. Syncope. JAm Med Dir Assoc 2013, 14:311-312.
76. Vinik A.I., Maser R.E., Ziegler D. Autonomic imbalance: Prophet of doom or scope for hope?. Diabet Med 2011, 28:643-651.